rs13234819

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001220.5(CAMK2B):​c.66-19145C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.386 in 151,898 control chromosomes in the GnomAD database, including 11,782 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 11782 hom., cov: 33)

Consequence

CAMK2B
NM_001220.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.794

Publications

5 publications found
Variant links:
Genes affected
CAMK2B (HGNC:1461): (calcium/calmodulin dependent protein kinase II beta) The product of this gene belongs to the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells, the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a beta chain. It is possible that distinct isoforms of this chain have different cellular localizations and interact differently with calmodulin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
CAMK2B Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 40
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina
  • intellectual disability, autosomal dominant 54
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001220.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001220.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAMK2B
NM_001220.5
MANE Select
c.66-19145C>T
intron
N/ANP_001211.3
CAMK2B
NM_001293170.2
c.66-19145C>T
intron
N/ANP_001280099.1Q13554-2
CAMK2B
NM_172078.3
c.66-19145C>T
intron
N/ANP_742075.1Q13554-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAMK2B
ENST00000395749.7
TSL:1 MANE Select
c.66-19145C>T
intron
N/AENSP00000379098.2Q13554-1
CAMK2B
ENST00000440254.6
TSL:1
c.66-19145C>T
intron
N/AENSP00000397937.2Q13554-2
CAMK2B
ENST00000395747.6
TSL:1
c.66-19145C>T
intron
N/AENSP00000379096.2Q13554-5

Frequencies

GnomAD3 genomes
AF:
0.386
AC:
58550
AN:
151780
Hom.:
11758
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.441
Gnomad AMI
AF:
0.340
Gnomad AMR
AF:
0.334
Gnomad ASJ
AF:
0.391
Gnomad EAS
AF:
0.0574
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.382
Gnomad MID
AF:
0.418
Gnomad NFE
AF:
0.396
Gnomad OTH
AF:
0.415
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.386
AC:
58608
AN:
151898
Hom.:
11782
Cov.:
33
AF XY:
0.381
AC XY:
28297
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.442
AC:
18310
AN:
41446
American (AMR)
AF:
0.333
AC:
5095
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.391
AC:
1358
AN:
3472
East Asian (EAS)
AF:
0.0576
AC:
298
AN:
5176
South Asian (SAS)
AF:
0.283
AC:
1361
AN:
4804
European-Finnish (FIN)
AF:
0.382
AC:
4017
AN:
10528
Middle Eastern (MID)
AF:
0.405
AC:
119
AN:
294
European-Non Finnish (NFE)
AF:
0.396
AC:
26878
AN:
67882
Other (OTH)
AF:
0.409
AC:
863
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1865
3731
5596
7462
9327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.392
Hom.:
15194
Bravo
AF:
0.382
Asia WGS
AF:
0.190
AC:
663
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.7
DANN
Benign
0.55
PhyloP100
-0.79
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs13234819;
hg19: chr7-44342969;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.